Galmed Pharmaceuticals Ltd. (GLMD) Financials

Stock symbol GLMD is outdated, potentially delisted? Maybe it is available on other exchange?

Ticker GLMD was renamed to EOCN effective 2026-09-10.

GLMD Assets vs Liabilities

Date	Assets	Liabilities
June 30, 2026	18.3 million	5.5 million
March 31, 2026	16.0 million	2.1 million
Dec. 31, 2025	18.6 million	2.8 million
Sept. 30, 2025	21.6 million	2.5 million

GLMD Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
June 30, 2026	-2.1 million	156000
March 31, 2026	-2.5 million	156000
Dec. 31, 2025	-1.9 million	240000
Sept. 30, 2025	-1.9 million	105000

GLMD Net Income

No data available :(

GLMD Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
June 30, 2026	11.4 million	-	46000
March 31, 2026	15.5 million	-	-
Dec. 31, 2025	18.2 million	-	-
Sept. 30, 2025	19.1 million	-	-

GLMD Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
June 30, 2026	952168
March 31, 2026	822674
Dec. 31, 2025	6.6 million
Sept. 30, 2025	682560

GLMD Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
June 30, 2026	-	1.8 million	993000	-
March 31, 2026	-	1.4 million	684000	-
Dec. 31, 2025	-	2.1 million	946000	-
Sept. 30, 2025	-	1.1 million	1.0 million	-

GLMD Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
June 30, 2026	-	-
March 31, 2026	-	-
Dec. 31, 2025	-	-
Sept. 30, 2025	-	-

GLMD

Price: $4.63

52 week price:

0.41

13.20

Earnings Per Share: -14.29 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Israel

Volume: 176487

Ebitda: -2.7 million

Market Capitalization: 4.1 million

Links:

GLMD on Yahoo Finance